We are live on ! Find out more
IMA

ImageneBio Inc
IMA

57 hedge funds and large institutions have $49.1M invested in ImageneBio Inc in 2024 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 11 increasing their positions, 20 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

3% more capital invested

Capital invested by funds: $47.9M → $49.1M (+$1.28M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.14% less ownership

Funds ownership: 5.77% → 5.63% (-0.14%)

19% less funds holding

Funds holding: 70 → 57 (-13)

45% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 20

72% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 18

Holders
57
Holders Change
-13
Holders Change %
-18.57%
% of All Funds
0.82%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
5
Increased
11
Reduced
20
Closed
18
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
FIA
FNY Investment Advisers
New York
+$390K
2
BCM
BML Capital Management
Indiana
+$233K
3
VAM
Vazirani Asset Management
New York
+$195K
4
BP
BBR Partners
New York
+$185K
5
BCM
Bridgeway Capital Management
Texas
+$128K

Top Sellers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
-$363K
2
Northern Trust
Northern Trust
Illinois
-$284K
3
Verition Fund Management
Verition Fund Management
Connecticut
-$223K
4
Millennium Management
Millennium Management
New York
-$177K
5
Two Sigma Investments
Two Sigma Investments
New York
-$135K
Name Holding Trade Value Shares
Change 		Change in
Stake
AVLSA
1
Atlas Venture Life Science Advisors
Massachusetts
$8.68M – – –
BI
2
BVF Inc
California
$8.25M – – –
BOCH
3
Blue Owl Capital Holdings
New York
$7.08M – – –
O
4
OrbiMed
New York
$6.12M – – –
OFM
5
Omega Fund Management
Massachusetts
$3.89M – – –
Vanguard Group
6
Vanguard Group
Pennsylvania
$2.4M +$34K +1,683 +1%
Adage Capital Partners
7
Adage Capital Partners
Massachusetts
$1.71M – – –
BCM
8
BML Capital Management
Indiana
$1.25M +$233K +11,514 +24%
NMC
9
NEA Management Company
Maryland
$1.04M +$50.6K +2,501 +5%
AI
10
Acuitas Investments
Washington
$778K +$83.9K +4,148 +12%
Renaissance Technologies
11
Renaissance Technologies
New York
$693K -$128K -6,317 -16%
Jacobs Levy Equity Management
12
Jacobs Levy Equity Management
New Jersey
$673K -$60K -2,969 -8%
SI
13
Sofinnova Investments
California
$662K – – –
BlackRock
14
BlackRock
New York
$609K -$4.49K -222 -0.8%
Acadian Asset Management
15
Acadian Asset Management
Massachusetts
$562K – – –
Geode Capital Management
16
Geode Capital Management
Massachusetts
$469K +$24.1K +1,194 +6%
Millennium Management
17
Millennium Management
New York
$431K -$177K -8,774 -30%
FIA
18
FNY Investment Advisers
New York
$400K +$390K +19,282 New
Two Sigma Advisers
19
Two Sigma Advisers
New York
$350K +$48.7K +2,409 +17%
Barclays
20
Barclays
United Kingdom
$338K -$1.23K -61 -0.4%
Citadel Advisors
21
Citadel Advisors
Florida
$285K -$134K -6,640 -33%
BCM
22
Bridgeway Capital Management
Texas
$274K +$128K +6,342 +92%
Two Sigma Investments
23
Two Sigma Investments
New York
$271K -$135K -6,681 -34%
BP
24
BBR Partners
New York
$225K +$185K +9,166 +550%
VAM
25
Vazirani Asset Management
New York
$200K +$195K +9,639 New
1
2 3

IMA Hedge Fund Activity: Q3 2024 in Review

57 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in ImageneBio Inc (IMA) for Q3 2024, worth a combined $49.1M — up 2.7% from $47.9M a quarter earlier.

Sellers outnumbered buyers: 18 funds closed out of IMA and 5 opened new positions — a net loss of 13 holders — while 20 trimmed existing stakes and 11 added.

The largest buyer was FNY Investment Advisers, opening a new position worth an estimated $390K. The largest seller was Goldman Sachs, cutting an estimated $363K.

  • 57 institutional investors held ImageneBio Inc (IMA) as of Q3 2024, down from 70 in Q2 2024.
  • Funds reported $49.1M of ImageneBio Inc stock for Q3 2024, up 2.7% quarter-over-quarter.
  • 5 funds opened new ImageneBio Inc positions in Q3 2024 and 18 closed out, a net change of -13 holders.
  • The largest ImageneBio Inc buyer in Q3 2024 was FNY Investment Advisers, an estimated $390K added.
  • The largest ImageneBio Inc seller in Q3 2024 was Goldman Sachs, an estimated $363K sold.

Based on aggregated 13F filings for Q3 2024.